Wealth Enhancement Advisory Services, LLC Astrazeneca PLC Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 324,027 shares of AZN stock, worth $27 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
324,027
Previous 311,600
3.99%
Holding current value
$27 Million
Previous $22.9 Million
1.13%
% of portfolio
0.04%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,433Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...